bi-505
mAbexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT01025206)
Timeline
Indications
Mechanism of action
- Intercellular adhesion molecule-1ANTAGONIST
ICAM1 antagonist
- Intercellular adhesion molecule-1INHIBITOR
ICAM1 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109482 ↗
Also known as
- bi-505
- bi-505
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02756728 | Phase 1/Phase 2 (Phase 2) | May 1, 2016 | BioInvent International AB, University of Pennsylvania |
| NCT01838369 | Phase 2 | Mar 1, 2013 | BioInvent International AB |
| NCT01025206 | Phase 1 | Dec 1, 2009 | BioInvent International AB, University of Utah |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioInvent International AB | For profit | 3 | 3 | 2 | 2009 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Utah | Academic/Hospital | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1